Guardant Health (GH) Income towards Parent Company (2017 - 2026)

Guardant Health has reported Income towards Parent Company for 10 years, with the latest figure at -$120.1 million in Q2 2026.

• Quarterly Income towards Parent Company fell 20.26% year-over-year to -$120.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$453.4 million (down 9.57% YoY) and the FY2025 annual result came in at -$416.3 million, up 4.61% from the prior year.
• Income towards Parent Company fell to -$120.1 million in Q2 2026 per GH's latest filing, from -$112.1 million in the prior quarter.
• Over five years, Income towards Parent Company peaked at -$72.8 million in Q2 2023 and troughed at -$229.4 million in Q2 2022.
• A 5-year average of -$123.3 million and a median of -$113.5 million in 2024 frame the typical range for Income towards Parent Company.
• The sharpest annual moves came in 2022 and 2023: Income towards Parent Company tumbled 135.13% in 2022, then jumped 68.28% in 2023.
• Over 5 years, Income towards Parent Company stood at -$139.9 million in 2022, then slumped by 33.67% to -$187.0 million in 2023, then jumped by 40.65% to -$111.0 million in 2024, then fell by 15.75% to -$128.5 million in 2025, then gained by 6.5% to -$120.1 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered -$120.1 million, -$112.1 million, and -$128.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.